Physician profile
Julia K Bishop
NPI 1215040126
$1,681.17
in general payments reported to CMS, 2019-2025
21 companies · $388 in 2025
The $388 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174 · 2021: $156 · 2022: $214 · 2023: $280 · 2024: $470 · 2025: $388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,137.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $302.79 | 2023-2025 | Myfembree, Gemtesa |
| Amgen INC. | $249.59 | 2022-2025 | Evenity, Prolia |
| Mayne Pharma Commercial LLC | $188.39 | 2023-2025 | |
| Olympus America INC. | $138.87 | 2019 | |
| Hologic Sales and Service, LLC | $132.63 | 2021-2024 | Omni Hysteroscope, Acessa Provu System, Coolseal Generator |
| Pfizer INC. | $125.08 | 2021-2023 | |
| Astellas Pharma Global Development | $122.05 | 2024 | Veozah |
| Radius Health, INC. | $108.11 | 2024 | Tymlos |
| Vertex Pharmaceuticals Incorporated | $51.34 | 2025 | |
| Myovant Sciences INC. | $36.84 | 2022 | |
| Coloplast Corp | $29.95 | 2022 | |
| Conmed Corporation | $28.87 | 2025 | Airseal |
| Avion Pharmaceuticals | $27.84 | 2021-2022 | |
| Coopersurgical, INC. | $27.30 | 2023-2024 | Paragard T 380a, Paragard T 380a |
| Karl Storz Endoscopy-America | $22.20 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $18.17 | 2025 | Veozah |
| Exact Sciences Corporation | $17.95 | 2023 | Cologuard Collection Kit |
| 180 Medical, INC. | $13.61 | 2024 | |
| Boston Scientific Corporation | $13.44 | 2022 | |
| Allergan, INC. | $13.28 | 2019 | |
| Exeltis, USA INC. | $12.87 | 2023 | Tyblume |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Bishop listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.